Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (14), 2091-2093
- https://doi.org/10.1016/0959-8049(94)00350-e
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancerCancer, 1993
- Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trialAnnals of Oncology, 1991
- Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.Journal of Clinical Oncology, 1991
- An Early Phase II Study of 5-Fluorouracil Combined with Cisplatinum as a Second Line Chemotherapy against Metastatic Gastric CancerJapanese Journal of Clinical Oncology, 1991
- Pilot Phase II Study of Cis-diamminedichioroplatinum (II) against Metastatic Gastric CancersJapanese Journal of Clinical Oncology, 1990
- Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- A phase II study of cisplatin in advanced gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Chemotherapieprotokoll zur Behandlung des metastasierenden Magenkarzinoms: Methotrexat, Adriamycin und 5-FluorouracilDeutsche Medizinische Wochenschrift (1946), 1982